Safety Study to Evaluate LY3114062 in Participants With Inflammatory Arthritis

NCT02144272 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

Inflammatory Arthritis

Interventions

DRUG: LY3114062 SC
DRUG: Placebo
DRUG: LY3114062 IV

Sponsor

Eli Lilly and Company